CAROSATI, Emanuele
 Distribuzione geografica
Continente #
NA - Nord America 1.117
EU - Europa 988
AS - Asia 545
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 2.656
Nazione #
US - Stati Uniti d'America 1.107
UA - Ucraina 211
SE - Svezia 197
IE - Irlanda 194
IT - Italia 176
VN - Vietnam 176
HK - Hong Kong 133
SG - Singapore 130
CN - Cina 64
DE - Germania 51
FI - Finlandia 50
RU - Federazione Russa 42
GB - Regno Unito 28
TR - Turchia 15
KR - Corea 11
FR - Francia 9
CA - Canada 6
CH - Svizzera 6
AT - Austria 5
BE - Belgio 5
GR - Grecia 4
IR - Iran 4
MX - Messico 4
NL - Olanda 4
UZ - Uzbekistan 4
PL - Polonia 3
CI - Costa d'Avorio 2
CL - Cile 2
EU - Europa 2
IN - India 2
JP - Giappone 2
LB - Libano 2
RO - Romania 2
CZ - Repubblica Ceca 1
IQ - Iraq 1
MY - Malesia 1
Totale 2.656
Città #
Chandler 264
Dublin 194
Dong Ket 172
Hong Kong 132
Jacksonville 100
San Mateo 100
Singapore 99
Boardman 73
Perugia 73
Altamura 49
Medford 47
Princeton 47
Wilmington 42
Lawrence 38
Andover 32
Ann Arbor 28
Beijing 28
Fremont 16
Des Moines 15
Izmir 15
Città Di Castello 11
Saint Petersburg 11
Seoul 10
Ashburn 9
Philadelphia 9
Falls Church 8
San Diego 7
Helsinki 6
Santa Clara 6
Brussels 5
Mcallen 5
New York 5
Ottawa 5
Arak 4
Hanoi 4
Norwalk 4
Puebla City 4
Alameda 3
Auburn Hills 3
Moscow 3
San Paolo di Civitate 3
Tappahannock 3
Woodbridge 3
Abidjan 2
Athis-Mons 2
Bologna 2
Chicago 2
Dallas 2
Den Haag 2
Florence 2
Guangdong 2
Laurel 2
Lausanne 2
Mascalucia 2
Messina 2
Milan 2
Olgiate Olona 2
Pedrengo 2
Redmond 2
Timisoara 2
Tokyo 2
Verona 2
Aurisina 1
Blue Bell 1
Clearwater 1
Corciano 1
Düsseldorf 1
Essen 1
Fort Worth 1
Frankfurt am Main 1
Genova 1
Halle 1
Las Vegas 1
Latina 1
Nanning 1
Narni 1
Redwood City 1
Santa Maria Di Sala 1
Santiago 1
Simi Valley 1
Totale 1.751
Nome #
1,4-Dihydropyridine Scaffold in Medicinal Chemistry, The Story So Far And Perspectives (Part 2): Action in Other Targets and Antitargets 192
1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspectives (part 1): action in ion channels and GPCRs 178
Discovery of Novel and Cardioselective Diltiazem-like Calcium Channel Blockers via Virtual Screening 93
Inhibitor of Ovarian Cancer Cells Growth by Virtual Screening: A New Thiazole Derivative Targeting Human Thymidylate Synthase 82
Calcium channel antagonists discovered by a multidisciplinary approach 75
Use of a Combined GLUE/ALMOND Approach in QSAR-Studies on (aryl) Bridged 2-Aminobenzonitriles Inhibiting HIV-1 Reverse Transcriptase 72
MetaSite: Understanding Metabolism in Human Cytochromes from the Perspective of the Chemist 72
A New Promising Class of pyrazolobenzothiazine inhibitors of S. aureus NorA Efflux Pump 71
Absolute configuration and biological profile of two thiazinooxadiazol-3-ones with L-type calcium channel activity: a study of the structural effects 70
Hydrogen Bonding Interactions of Covalently-Bonded Fluorine Atoms: From Crystallographic Data to a New Angular Function in the GRID Force Field 69
Stereoselective Behavior of the Functional Diltiazem Analogue 1-[(4-Chlorophenyl)sulfonyl]-2-(2-thienyl)pyrrolidine, a New L-Type Calcium Channel Blocker 68
Transporter-Mediated Efflux Influences CNS Side Effects: ABCB1, from Antitarget to Target 66
FLAP: GRID Molecular Interaction Fields in Virtual Screening. Validation using the DUD Data Set 64
Side-Chain Modified Ergosterol and Stigmasterol Derivatives as Liver X Receptor Agonists 64
From 6-Aminoquinolone Antibacterials to 6-Amino-7-thiopyranopyridinylquinolone Ethyl Esters as Inhibitors of Staphylococcus aureus Multidrug Efflux Pumps. 61
QSAR Modeling and Data Mining Link Torsades de Pointes Risk to the Interplay of Extent of Metabolism, Active Transport, and hERG Liability 61
Recent improvement in the GRID Force Field. 1. The docking Procedure GLUE 61
The flavonoid scaffold as a template for the design of modulators of the vascular Ca(v)1.2 channels 60
Integrating Crystallography into Early Metabolism Studies 59
ADME-Space: A new tool for medicinal chemists to explore ADME properties 59
Discovery of Novel Inhibitors of the NorA Multidrug Transporter of Staphylococcus aureus. 56
Homodimeric enzymes as drug targets 55
Binding studies and GRIND/ALMOND-based 3D QSAR analysis of benzothiazine type K-ATP channel openers 55
Ligand Promiscuity between the Efflux Pumps Human P-Glycoprotein and S. aureus NorA 55
Characterization of Protein-Binding Sites and Ligands Using Molecular Interaction Fields 54
MetaSite: understanding CYP antitarget modelling for early toxicity detection 53
Ligand-based virtual screening and ADME-tox guided approach to identify triazolo-quinoxalines as folate cycle inhibitors 50
Ligands of Diltiazem Binding Site: An Overview of Some Chemotypes 48
A new class of selective myocardial calcium channel modulators. 2. Role of the acetal chain in oxadiazol-3-one derivatives. 47
Peptide studies by means of principal properties of amino acids derived from MIF descriptors 46
Large, chemically diverse dataset of log P measurements for benchmarking studies 45
A Novel Approach for Predicting P-Glycoprotein (ABCB1) Inhibition Using Molecular Interaction Fields 43
L-Type Calcium Channel Blockers: From Diltiazem to 1,2,4-Oxadiazol-5-ones via Thiazinooxadiazol-3-one Derivatives 43
VolSurf: a tool for drug ADME-properties prediction 42
Pyrazolo[4,3-c][1,2]benzothiazines 5,5-Dioxide: A Promising New Class of Staphylococcus aureus NorA Efflux Pump Inhibitors 42
Recent improvement in the GRID Force Field. 2. A new Angular Function Derived from Crystallographic Data for describing Hydrogen Bonding Interactions of Covalenty-Bonded Fluorine Atoms 41
IAP antagonists: promising candidates for cancer therapy 40
Discovery of Novel, Potent, and Specific Cell-Death Inducers in the Jurkat Acute Lymphoblastic Leukemia Cell Line 40
Novel apoptosis inducers overcome IAP-mediated resistance of the renal cell carcinoma cell line ClearCa-2 39
Use of MIF-based VolSurf Descriptors in Physicochemical and Pharmacokinetic Studies 39
The Complexity of Molecular Interaction: Molecular Shape Fingerprints by the PathFinder Approach 37
Targeting Cystalysin, a Virulence Factor of Treponema denticola-Supported Periodontitis 36
On the catalytic role of the active site residue E121 of E. coli L-aspartate oxidase 34
Three-Dimensional Quantitative Structure-Properties Relationships 31
Modelling cytochromes P450 binding modes to predict P450 inhibition, metabolic stability and isoform selectivity 28
Nuove molecole per uso come agenti antitumorali 27
Novel apoptosis inducers in the acute lymphatic leukemia cell line JM 23
Totale 2.746
Categoria #
all - tutte 10.419
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.419


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020165 0 0 0 0 24 5 36 9 37 30 4 20
2020/2021569 1 34 23 32 119 40 27 2 50 21 34 186
2021/2022425 12 67 11 34 29 7 2 136 8 4 60 55
2022/2023755 49 141 13 76 65 86 0 33 261 1 23 7
2023/2024337 24 37 14 8 8 1 44 1 103 5 53 39
2024/2025151 13 60 24 52 2 0 0 0 0 0 0 0
Totale 2.746